Rosi Elia, Fastame Maria Thais, Di Cesare Antonella, Silvi Gianmarco, Pimpinelli Nicola, Prignano Francesca
Department of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.
J Clin Med. 2021 Dec 13;10(24):5841. doi: 10.3390/jcm10245841.
The Coronavirus Disease 2019 (COVID-19) pandemic, a global public health emergency, has changed dermatology practice and daily routine in just under two years. Much has been written in the literature about COVID-19-associated skin manifestations. Nevertheless, much less has been written regarding skin manifestations in patients affected by severe immune-mediated skin diseases, e.g., psoriasis and hidradenitis suppurativa, undergoing biological treatment during the COVID-19 outbreak. Thus, the aim of this article is to provide the reader with an overview of the cutaneous manifestations during the COVID-19 pandemic in this subset of patients.
2019冠状病毒病（COVID-19）大流行是一场全球突发公共卫生事件，在不到两年的时间里改变了皮肤科的诊疗实践和日常工作。关于COVID-19相关的皮肤表现，文献中已有大量报道。然而，关于在COVID-19疫情期间接受生物治疗的重度免疫介导性皮肤病（如银屑病和化脓性汗腺炎）患者的皮肤表现，相关报道则少得多。因此，本文旨在为读者概述这一特定患者群体在COVID-19大流行期间的皮肤表现。
